Concepedia

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Christel Fontaine, Vincent Renard, Heidi Van den Bulk, Peter Vuylsteke, Philippe Glorieux, Catherine Dopchie, Lore Decoster, Leen Vanacker, Evandro de Azambuja, Jacques De Grève,

Breast Cancer Research and Treatment · 2019 · 13 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations

, , +14

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.9K citations · Full text

, , +16

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

, , +15

Metastatic Behavior of Breast Cancer Subtypes

Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text

, , +14

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Gϋnter von Minckwitz, Andreas Schneeweiß, Sibylle Loibl et al. · The Lancet Oncology · 2014 · 1K citations

, , +12